Venture Investors Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
110
- Portfolio
-
17
- Exits
-
50
Venture Investors General Information
Description
Founded in 1982, Venture Investors is a venture capital firm based in Madison, Wisconsin. The firm focuses on the healthcare sector in the Midwest, with a national reach. The firm seeks to invest in companies operating in the therapeutic, diagnostic & tools, medical devices, and digital health sectors. It provides seed, early-stage, and growth capital.
Contact Information
Website
www.ventureinvestors.com
Year Founded
1982
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- University Research Park
- 510 Charmany Drive, Suite 250
- Madison, WI 53719
- United States
+1 (608) 000-0000
Venture Investors Investments (110)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| HistoSonics | 13-Dec-2022 | Later Stage VC | 00000 | Diagnostic Equipment | Startup | |
| 000000000 0000000 | 13-Sep-2022 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | 0000 0000 |
| 000000 000000 | 06-Jun-2022 | 0000 00000 | 00.00 | Other Healthcare Services | Generating Revenue | |
| 00000000 | 12-May-2022 | 00000 00000 | 0000 | Other Healthcare Technology Systems | Generating Revenue | 00000 000000 |
| 0000000 | 19-Nov-2021 | 00000 00000 | 000.00 | Surgical Devices | Pre-Clinical Trials | 00000 0000 |
| 000000 00000000 | 23-Jun-2021 | 00000 00000 | 00.00 | Educational Software | Generating Revenue | 0000 0000 |
| 00000 000000000000 | 19-Mar-2021 | 0000 00000 | 00.00 | Drug Discovery | Startup | |
| 0000000 0000000000 | 16-Feb-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 0000 00000 00.0 |
| EnsoData | 19-May-2020 | Later Stage VC | 00.000 | Other Healthcare Technology Systems | Generating Revenue | 00000 000000 |
| FluGen | 01-May-2020 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 0000 00000 00.0 |
Venture Investors Exits (50)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| HealthMyne | 01-Sep-2022 | Secondary Transaction - Private | |
| 0000000000 | 01-Nov-2021 | 000000000000000000 | |
| 000 00000000000 | 16-Oct-2020 | 000 00 00000000 | |
| 0000000 000000000 | 17-Sep-2020 | 000000000000000000 | 00000 |
| 000000 00000000000 | 01-Sep-2020 | 000000000 00000000 | |
| 000000000 00000000 | 01-Mar-2019 | 000 00 00000000 | |
| 000000000 | 25-Oct-2018 | 000000000000000000 | 000.00 |
| 000000000 | 01-Jan-2018 | 0000000000: 000000 | |
| EBI Life Sciences | 10-Nov-2017 | Out of Business | |
| Euthymics Bioscience | 01-Nov-2017 | Merger/Acquisition |
Venture Investors Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Venture Investors Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Venture Investors Team (18)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| David Arnstein | Chief Financial Officer | Madison, WI | |||
| James Adox | Executive Managing Director | 00 | 0 | 0 | Ann Arbor, MI |
| John Neis | Managing Director | 00 | 0 | 0 | Madison, WI |
| Paul Weiss Ph.D | Managing Director | 00 | 0 | 0 | Madison, WI |
| Scott Button | Managing Director | 00 | 0 | 0 | Madison, WI |
Venture Investors Co-Investors (52)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Arboretum Ventures | 3 | 0 |
|
|
|
| Capital Midwest Fund | 0 | 0 |
|
|
|
| Lumira Ventures | 0 | 0 |
|
|
|
| State of Wisconsin Investment Board | 0 | 0 |
|
|
|
| Beringea | 0 | 0 |
|
|